Pharmaceuticals
A Psychedelic May Soon Go to the FDA for Approval to Treat Trauma
MDMA, known as Ecstasy in the clubs, gained high marks in a clinical trial for PTSD
Stories by Jennifer M. Mitchell
Jennifer M. Mitchell is a professor in the departments of neurology and psychiatry at the University of California, San Francisco, a member of the U.C. Berkeley Center for the Science of Psychedelics, and deputy associate chief of staff for research and development at the San Francisco VA Medical Center. Credit: Nick Higgins
